Literature DB >> 7070963

The possible role of acetate in exercise hyperemia in dog skeletal muscle.

R P Steffen, J E McKenzie, F J Haddy.   

Abstract

The possible role of acetate in the genesis of exercise hyperemia was studied in five series of dogs. Intraarterial infusion of an isomotic solution of sodium acetate at 0.76 ml/min in the dog forelimb decreased the resistance to flow through skeletal muscle by 48%, primarily by decreasing resistance to flow through small vessels. Skin lymph flow and lymph protein concentration were unaffected. The hindlimb of the conscious dog took up acetate at rest (A-V difference, + 58.3 +/- 19.6 nmoles/ml) and put out acetate during treadmill exercise (A-V difference, -105.6 +/- 20.12 nmoles/ml); femoral venous blood acetate concentration increased by 145 nmoles/ml (control 195 nmoles/ml). In the gracilis muscle of the anesthetized dog, simulated exercise at 0.5, 1.0 or 2.0 Hz increased acetate tissue content (72, 248 and 442 nmoles/g, respectively), output (18,899, and 1,830 nmoles/100 g/min, respectively) and venous concentration (82, 49 and 39 nmoles/ml, respectively) and changes in tissue acetate content correlated with changes in vascular resistance r = 0.75, P less than 0.001. Intraarterial infusion of an isosmotic solution of sodium acetate in the quiescent gracilis muscle perfused at constant flow produced a significant (6%) decrease in resistance when arterial blood acetate was increased by a calculated 96 nmoles/ml. These studies suggest that acetate might be included among those metabolites that contribute to exercise hyperemia.U

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7070963     DOI: 10.1007/bf00581625

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  23 in total

1.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

2.  Local effects of various anions and H ions on dog limb and coronary vascular resistances.

Authors:  J I MOLNAR; J B SCOTT; E D FROHLICH; F J HADDY
Journal:  Am J Physiol       Date:  1962-07

3.  Production and utilization of free acetate in man.

Authors:  F LUNDQUIST
Journal:  Nature       Date:  1962-02-10       Impact factor: 49.962

Review 4.  Supply and utilization of acetate in mammals.

Authors:  F J Ballard
Journal:  Am J Clin Nutr       Date:  1972-08       Impact factor: 7.045

5.  Mechanisms of edema formation by histamine administered locally into canine forelimbs.

Authors:  G J Grega; R L Kline; D E Dobbins; F J Haddy
Journal:  Am J Physiol       Date:  1972-11

6.  Effects of histamine on lymph protein concentration and flow in the dog forelimb.

Authors:  F J Haddy; J B Scott; G J Grega
Journal:  Am J Physiol       Date:  1972-11

7.  Venous resistances in skeletal muscle and skin during local blood flow regulation.

Authors:  F J Nagle; J B Scott; B T Swindall; F J Haddy
Journal:  Am J Physiol       Date:  1968-04

8.  Metabolically linked vasoactive chemicals in local regulation of blood flow.

Authors:  F J Haddy; J B Scott
Journal:  Physiol Rev       Date:  1968-10       Impact factor: 37.312

9.  Myocardial depressant effects of sodium acetate.

Authors:  R L Kirkendol; J E Pearson; J D Bower; R D Holbert
Journal:  Cardiovasc Res       Date:  1978-02       Impact factor: 10.787

10.  Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding, and various diseases.

Authors:  C D Tollinger; H J Vreman; M W Weiner
Journal:  Clin Chem       Date:  1979-10       Impact factor: 8.327

View more
  2 in total

Review 1.  Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function.

Authors:  James Frampton; Kevin G Murphy; Gary Frost; Edward S Chambers
Journal:  Nat Metab       Date:  2020-03-30

2.  Coronary vasoactivity of acetate in dog and guinea-pig.

Authors:  N Yamada; R Bünger; C R Steinhart; R A Olsson
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.